Fortis Healthcare Ltd. has approved a two year extension of the tenure of its Managing Director & Chief Executive Officer, Dr Ashutosh Raghuvanshi, reaffirming the Board’s confidence in his leadership as the company enters its next phase of strategic growth and operational excellence. The reappointment, effective from March 19, 2027, is subject to shareholders’ approval.

The decision comes at a crucial time for India’s healthcare sector, which is witnessing sustained demand for tertiary and quaternary care, digital health integration, and infrastructure expansion. Leadership continuity is expected to strengthen Fortis Healthcare’s long term strategy, enabling the organization to build on its operational momentum while enhancing patient outcomes and shareholder value.

A cardiac surgeon turned healthcare executive, Dr. Raghuvanshi has been instrumental in driving Fortis Healthcare’s transformation since assuming leadership in 2019. Under his stewardship, the company has focused on improving operational efficiency, strengthening clinical governance, expanding high-end specialty services, and reinforcing patient centric care. His strategic approach has also emphasized technology adoption, institutional governance, and sustainable business growth.

Today, Fortis Healthcare is among India’s largest integrated healthcare providers, operating a network of 36 hospitals and over 400 diagnostic centres through Agilus Diagnostics. Backed by its parent company, IHH Healthcare, the group continues to expand its footprint while investing in advanced medical technologies, specialist talent, and world class clinical infrastructure.

The Board’s decision reflects confidence in the company’s strategic direction and recognizes the leadership that has helped Fortis strengthen its market position in an increasingly competitive healthcare landscape. With healthcare delivery rapidly evolving through digital innovation, precision medicine, and value based care, experienced leadership is expected to play a pivotal role in navigating future opportunities.

The extension also signals stability for investors and stakeholders as Fortis Healthcare continues to pursue capacity expansion, operational excellence, and clinical innovation. As India accelerates investments in healthcare infrastructure and quality care delivery, the hospital network remains focused on strengthening its centres of excellence, enhancing patient experience, and delivering sustainable long term growth.

Dr. Raghuvanshi’s renewed mandate reinforces Fortis Healthcare’s commitment to institutional continuity, strategic execution, and clinical excellence, positioning the organization to capitalize on emerging opportunities in one of the world’s fastest growing healthcare markets.